CL2008002730A1 - Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil - Google Patents

Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil

Info

Publication number
CL2008002730A1
CL2008002730A1 CL200802730A CL2008002730A CL2008002730A1 CL 2008002730 A1 CL2008002730 A1 CL 2008002730A1 CL 200802730 A CL200802730 A CL 200802730A CL 2008002730 A CL2008002730 A CL 2008002730A CL 2008002730 A1 CL2008002730 A1 CL 2008002730A1
Authority
CL
Chile
Prior art keywords
cream
photosensibile
pentoxyphiline
rosacea
ointment
Prior art date
Application number
CL200802730A
Other languages
English (en)
Inventor
Roberto Figueroa Liza Patricio
Original Assignee
Roberto Figueroa Liza Patricio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Figueroa Liza Patricio filed Critical Roberto Figueroa Liza Patricio
Priority to CL200802730A priority Critical patent/CL2008002730A1/es
Publication of CL2008002730A1 publication Critical patent/CL2008002730A1/es
Priority to US12/737,961 priority patent/US20110159077A1/en
Priority to PCT/CL2009/000011 priority patent/WO2010028515A2/es
Priority to JP2011526362A priority patent/JP2012502068A/ja
Priority to EP09812597.4A priority patent/EP2322181A4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL200802730A 2008-09-12 2008-09-12 Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil CL2008002730A1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CL200802730A CL2008002730A1 (es) 2008-09-12 2008-09-12 Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil
US12/737,961 US20110159077A1 (en) 2008-09-12 2009-08-25 Pentoxifilin-based dermatological pharmaceutical composition, for topical application, in cream, gel, solution, emulsion, liposome and microcapsule form
PCT/CL2009/000011 WO2010028515A2 (es) 2008-09-12 2009-08-25 Una composición farmacéutica dermatológica, a base de pentoxifilina, de aplicación tópica, en forma de crema, gel ungüento, solución, en emulsión, en liposomas y en microcápsulas
JP2011526362A JP2012502068A (ja) 2008-09-12 2009-08-25 クリーム、ゲル、軟膏、溶液の形態、乳剤、リポソーム及びマイクロカプセル状の皮膚に適用するペントキシフィリンに基づく皮膚用医薬組成物
EP09812597.4A EP2322181A4 (en) 2008-09-12 2009-08-25 PENTOXIFILINE-BASED DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION IN CREAM, GEL, SALT, SOLUTION, EMULSION, LIPOSOME AND MICROCAPSEL FORMS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL200802730A CL2008002730A1 (es) 2008-09-12 2008-09-12 Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil

Publications (1)

Publication Number Publication Date
CL2008002730A1 true CL2008002730A1 (es) 2008-10-24

Family

ID=40261511

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200802730A CL2008002730A1 (es) 2008-09-12 2008-09-12 Composicion farmaceutica dermatologica, de aplicacion topica, en forma de crema, gel, unguento, solucion, emulsion que comprende 1a 99% de pentoxifilina, 0,1 a 80% de crema base y 0,1 a 75% de liposomas, util para rosacea, trastornos con fotosensibil

Country Status (5)

Country Link
US (1) US20110159077A1 (es)
EP (1) EP2322181A4 (es)
JP (1) JP2012502068A (es)
CL (1) CL2008002730A1 (es)
WO (1) WO2010028515A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN112402367B (zh) * 2020-11-26 2022-03-18 迪沙药业集团有限公司 一种甲硝唑组合物及制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0692290B2 (ja) * 1986-02-18 1994-11-16 鐘紡株式会社 皮膚化粧料
US5030442A (en) * 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
JP2599492B2 (ja) * 1990-08-21 1997-04-09 第一製薬株式会社 リポソーム製剤の製造法
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
DE69732308T2 (de) * 1996-09-27 2005-06-02 Jagotec Ag Arzneistoffverabreichungssystem mit hyaluronsäure
US5985592A (en) * 1997-06-05 1999-11-16 Dalhousie University Uses for pentoxifylline or functional derivatives/metabolites thereof
WO2002089743A2 (en) * 2001-05-09 2002-11-14 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US20040224012A1 (en) * 2001-10-05 2004-11-11 Pichit Suvanprakorn Topical application and methods for administration of active agents using liposome macro-beads
US20030138467A1 (en) * 2001-12-27 2003-07-24 Avon Products, Inc. Methods for improving the aesthetic appearance of skin
US20040092482A1 (en) * 2002-11-07 2004-05-13 Gupta Shyam K. Hydroxy acids based delivery systems for skin resurfacing and anti-aging compositions
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20040147534A1 (en) * 2003-01-23 2004-07-29 Foote Mary Ann Topical composition and method for treating occlusive wounds
EP1600158A1 (en) * 2004-05-26 2005-11-30 Galderma Research & Development, S.N.C. Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof
WO2006002365A2 (en) * 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
JP2006213696A (ja) * 2005-01-07 2006-08-17 Rohto Pharmaceut Co Ltd 皮膚外用剤
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
FR2902998B1 (fr) * 2006-07-03 2012-09-21 Oreal Utilisation d'au moins un derive c-glycoside a titre d'agent apaisant

Also Published As

Publication number Publication date
EP2322181A4 (en) 2014-09-10
JP2012502068A (ja) 2012-01-26
WO2010028515A3 (es) 2010-05-06
US20110159077A1 (en) 2011-06-30
WO2010028515A2 (es) 2010-03-18
EP2322181A2 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
IL232447A0 (en) Local topical administration formulations containing indoxacarb
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
CL2007001972A1 (es) Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metilpiridin-3-ilamino)-5-metilpirimidin-4-iloxi]piperidin-1-carboxilico, moduladores del metabolismo; composicion farmaceutica; y su uso para tratar trastornos metabolicos.
EP2224973A4 (en) PRESERVATIVE FOR COSMETICS, BODY CARE AND PHARMACEUTICAL COMPOSITIONS
ZA201002203B (en) Cosmetic or pharmaceutical composition for topical application
CL2007002446A1 (es) Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante.
PT2344198T (pt) Preparações farmacêuticas à base de lípidos para aplicação tópica
EP2275104A3 (en) Pharmaceutical and cosmetic composition including lactoferrin, ciclopirox and etidronic acid
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
HUE061596T2 (hu) Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
BR112015008951A2 (pt) composição de loção tópica de armazenamento estável, método para o tratamento de dermatoses responsivas a corticosteroides e método para a preparação da composição de loção tópica
EP2643002A4 (en) PHARMACEUTICAL FORMULATIONS WITH CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION
CL2008000610A1 (es) Composicion en forma de dosificacion transdermica o transmucosa que comprende una relacion en peso de buprenorfina a naloxona entre 2,1:1 y 8:1, util para el tratamiento del dolor.
CL2012003038A1 (es) Polietilenglicol conjugado a factor viia; composicion farmacéutica que comprende dicho polietilenglicol conjugado a factor viia; uso de una composicion farmaceutica para tratar enfermedad o trauma de la coagulacion de la sangre en un paciente que la necesita; proceso para preparar el siguiente polietilenglicol conjugado a factor viia.
WO2013142672A3 (en) Personal care compositions and methods
IT1398268B1 (it) Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico
CL2014001477A1 (es) Producto de chocolate con una cobertura tropicalizada, que comprende chocolate y un liquido humectante y un nucleo de chocolate no-tropicalizado; y metodo para elaborar un producto de chocolateria.
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
WO2008145747A3 (en) Skin moisturizer and use thereof
BRPI0817883A2 (pt) Produto aprimorado de uso tópico para alivio de dores
AR049036A1 (es) Preparaciones topicas que contienen ambroxol
EP2991681A4 (en) TOPICAL COMPOSITION AND CARRIER FOR THE ADMINISTRATION OF PHARMACEUTICAL OR COSMETIC ACTIVE SUBSTANCES
EP3068436A4 (en) Topical pharmaceutical, cosmetic and disinfectant compositions comprising phosphatidylcholine
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde